T
he popular Dysport Challenge — in which consumers can save $150 when they try the botulinum toxin wrinkle filler for their frown lines — now has over 100,000 registrants. Originally it was to run March through April 2010, but due to its success, it’s been extended through September 2010, so more patients can take advantage of the offer.
The challenge allows patients to save $75 when they try Dysport. If they “love it,” they receive $75 off their next Dysport treatment; if they don’t, patients receive a $75 rebate off another botulinum toxin type A product, such as Botox.
Over 91.2 percent of 22,416 patients who took the challenge from March 1 through May 9, 2010, made “Love It,” according to Medicis, the maker of Dysport. Only 2.6 percent of all registered patients have made a selection to “Leave It” since the program began.
When the challenge started, Jonah Shacknai, the chief executive of Medicis, said,“We are so confident that we are literally willing to bet our money that patients will love their Dysport treatment.”
Approved by the FDA in April 2009 to treat frown lines between the eyebrows, Dysport works much like Botox and is Botox’s first comparable competitor in the U.S. cosmetic market. Dysport works by a process called neuromuscular blocking, which relaxes small muscles in the face and forehead that cause wrinkles to form.
In the release on passing the 100,000 registrant milestone, Shacknai said:
“We are pleased to announce this tremendous support by both physicians and patients for the Dysport Challenge. Medicis made a bold statement of confidence in the brand by offering patients the opportunity to try Dysport and save up to $150 total.”
Open to patients 18 and older, complete Dysport Challenge details are available at www.DysportUSA.com. Advancements in Dermatology and Skin Speaks Spa M.D. offers Dysport to patients in the Twin Cities area.
